190 related articles for article (PubMed ID: 38062876)
1. DBC1 maintains skeletal muscle integrity by enhancing myogenesis and preventing myofibre wasting.
Liang N; He J; Yan J; Han X; Zhang X; Niu Y; Sha W; Li J
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):255-269. PubMed ID: 38062876
[TBL] [Abstract][Full Text] [Related]
2. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
[TBL] [Abstract][Full Text] [Related]
3. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
[TBL] [Abstract][Full Text] [Related]
4. miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle.
Hudson MB; Rahnert JA; Zheng B; Woodworth-Hobbs ME; Franch HA; Price SR
Am J Physiol Cell Physiol; 2014 Aug; 307(4):C314-9. PubMed ID: 24871856
[TBL] [Abstract][Full Text] [Related]
5. CREG1 deficiency impaired myoblast differentiation and skeletal muscle regeneration.
Song H; Tian X; He L; Liu D; Li J; Mei Z; Zhou T; Liu C; He J; Jia X; Yang Z; Yan C; Han Y
J Cachexia Sarcopenia Muscle; 2024 Apr; 15(2):587-602. PubMed ID: 38272853
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
Pototschnig I; Feiler U; Diwoky C; Vesely PW; Rauchenwald T; Paar M; Bakiri L; Pajed L; Hofer P; Kashofer K; Sukhbaatar N; Schoiswohl G; Weichhart T; Hoefler G; Bock C; Pichler M; Wagner EF; Zechner R; Schweiger M
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):93-107. PubMed ID: 36351437
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis.
Choi S; Jeong HJ; Kim H; Choi D; Cho SC; Seong JK; Koo SH; Kang JS
Autophagy; 2019 Jun; 15(6):1069-1081. PubMed ID: 30653406
[TBL] [Abstract][Full Text] [Related]
9. m
Liu Y; Zhou T; Wang Q; Fu R; Zhang Z; Chen N; Li Z; Gao G; Peng S; Yang D
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1210-1223. PubMed ID: 35142084
[TBL] [Abstract][Full Text] [Related]
10. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
[TBL] [Abstract][Full Text] [Related]
11. Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway.
Fang WY; Tseng YT; Lee TY; Fu YC; Chang WH; Lo WW; Lin CL; Lo YC
Br J Pharmacol; 2021 Aug; 178(15):2998-3016. PubMed ID: 33788266
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational modifications control FoxO3 activity during denervation.
Bertaggia E; Coletto L; Sandri M
Am J Physiol Cell Physiol; 2012 Feb; 302(3):C587-96. PubMed ID: 22094330
[TBL] [Abstract][Full Text] [Related]
13. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
[TBL] [Abstract][Full Text] [Related]
14. Protein therapy of skeletal muscle atrophy and mechanism by angiogenic factor AGGF1.
He Z; Song Q; Yu Y; Liu F; Zhao J; Un W; Da X; Xu C; Yao Y; Wang QK
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):978-991. PubMed ID: 36696895
[TBL] [Abstract][Full Text] [Related]
15. Myricanol rescues dexamethasone-induced muscle dysfunction via a sirtuin 1-dependent mechanism.
Shen S; Liao Q; Liu J; Pan R; Lee SM; Lin L
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):429-444. PubMed ID: 30793539
[TBL] [Abstract][Full Text] [Related]
16. Foxo3 Knockdown Mediates Decline of
Gellhaus B; Böker KO; Gsaenger M; Rodenwaldt E; Hüser MA; Schilling AF; Saul D
Cells; 2023 Aug; 12(17):. PubMed ID: 37681900
[TBL] [Abstract][Full Text] [Related]
17. Combined fibre atrophy and decreased muscle regeneration capacity driven by mitochondrial DNA alterations underlie the development of sarcopenia.
Kimoloi S; Sen A; Guenther S; Braun T; Brügmann T; Sasse P; Wiesner RJ; Pla-Martín D; Baris OR
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2132-2145. PubMed ID: 35765148
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle-specific DJ-1 ablation-induced atrogenes expression and mitochondrial dysfunction contributing to muscular atrophy.
Zhang S; Yan H; Ding J; Wang R; Feng Y; Zhang X; Kong X; Gong H; Lu X; Ma A; Hua Y; Liu H; Guo J; Gao H; Zhou Z; Wang R; Chen P; Liu T; Kong X
J Cachexia Sarcopenia Muscle; 2023 Oct; 14(5):2126-2142. PubMed ID: 37469245
[TBL] [Abstract][Full Text] [Related]
19. The body region specificity in murine models of muscle regeneration and atrophy.
Yoshioka K; Kitajima Y; Seko D; Tsuchiya Y; Ono Y
Acta Physiol (Oxf); 2021 Jan; 231(1):e13553. PubMed ID: 32875719
[TBL] [Abstract][Full Text] [Related]
20. Prosaposin expression in the regenerated muscles of mdx and cardiotoxin-treated mice.
Li C; Gao HL; Shimokawa T; Nabeka H; Hamada F; Araki H; Cao YM; Kobayashi N; Matsuda S
Histol Histopathol; 2013 Jul; 28(7):875-92. PubMed ID: 23325523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
